A price has to be paid for everything.

Action and inaction.

The price to reimburse a drug is the drug’s price tag.

The price for denying reimbursement is what’s paid to live with the status quo.

If a payer makes intentional efforts to block a patient from receiving a drug that they could benefit from, are they ready to pay the price? Are they willing to pay the price?

Right drug for the right patient at the right time is an important mantra. If their systems aren’t equipped to efficiently handle the logistics, perhaps THAT’S a problem worth chasing after.